Section divider

Helping Ivoirians stay healthy since the 1980s.

  • Jhpiego deployed an electronic platform for monitoring HIV-positive patients on antiretroviral therapy (ART) to help track patients and reduce those who are lost to follow-up or who are being treated at multiple health facilities. This platform was deployed in 170 sites across 27 health regions and 59 health districts, with 158,816 clients on ART registered in the platform. About 95% of these patients were retained in care and 94% were virally suppressed, contributing to the country’s UNAIDS 95-95-95 goals.
  • Jhpiego introduced cervical cancer screening for HIV-positive women using visual inspection with acetic acid coupled with immediate treatment (if needed) via cryotherapy. After scaling up this program and successfully handing it over to the government in 2015, Jhpiego began working to introduce the HPV vaccine and HPV self-testing.
  • With the Ministry of Health and Ministry of Education, Jhpiego built the capacity of vaccinators, supported vaccinations in schools, and coordinated the introduction of vaccinating 9-year-old girls against HPV in all health districts nationwide.
  • The MOMENTUM Country and Global Leadership project works on integrated health care with eight ministry directorates and programs, 14 regions and 48 districts. The project has improved availability and application of guidelines and training materials on maternal, newborn and child health and community-based interventions in integrated intervention areas, including maternal and newborn health and malaria in pregnancy. The project also revitalized national technical working groups on malaria prevention in pregnant women and children 0–5 years and maternal and child health.

Our Work in Côte d’Ivoire

MOMENTUM Country and Global Leadership

MOMENTUM is a suite of projects, funded by the U.S. Agency for International Development, that aims to accelerate reductions in maternal, newborn and child mortality and morbidity in high-burden countries by increasing host country commitment and capacity to provide high-quality, integrated health care. Each of the projects has a specific focus area; together they provide a comprehensive, flexible package of support for countries as they overcome context-specific health challenges towards sustainable development. The six-year, Jhpiego-led MOMENTUM Country and Global Leadership project focuses on: 1) providing targeted technical and capacity development assistance to our missions, partner countries and local organizations; and 2) contributing to global technical leadership and policy dialogue for improved maternal, newborn and child health outcomes. Jhpiego’s sub-partners under this project are: Save the Children, Johns Hopkins University International Vaccine Access Center, Quicksand, Matchboxology, BAO Systems, Avenir Health, McKinsey and Company, PACT, Institute for Healthcare Improvement, Christian Connections for International Health and Ubora Quality Institute.

Reaching Impact, Saturation, and Epidemic Control (RISE)

RISE is a five-year global project funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID). RISE works with countries to achieve a shared vision of attaining and maintaining epidemic control, with stronger local partners capable of managing and achieving results through sustainable, self-reliant and resilient health systems by 2024. RISE’s contributions to this work will lead to fewer new HIV infections, decreased HIV-related morbidity and mortality, and increased quality of life for people living with HIV. With USAID PEPFAR investments, RISE supports countries to achieve and maintain epidemic control by providing strategic technical assistance and direct service delivery to improve HIV prevention, case finding, treatment programming and viral load suppression. The primary objectives of the RISE project are to: 1) attain and maintain HIV epidemic control among at-risk adult men, women and priority populations; 2) attain and maintain HIV epidemic control among key populations; 3) strengthen health systems including improved program management, health information systems, human resources for health and financial systems to ensure attainment and maintenance of epidemic control; and 4) support the transition of direct funding and implementation to capable local partners to meet the PEPFAR goal of 70% of funding to local partners by 2020. The project is led by Jhpiego with the following partners: ICAP at Columbia University, Management Sciences for Health, Anova, BAO Systems, Johns Hopkins University Center for Public Health and Human Rights and Mann Global Health. RISE is currently active in several countries, including Côte d’Ivoire.

Support to the HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium

The human papillomavirus (HPV) vaccine is one of the most effective ways to prevent cervical cancer and other HPV-related diseases, yet there is still disproportionate access to it, specifically among girls and adolescents in low- and middle-income countries. The HAPPI Consortium, funded by the Gates Foundation, was launched to increase and sustain program quality and accelerate coverage of HPV vaccination. John Snow, Inc. and HAPPI Consortium partners Jhpiego, the Clinton Health Access Initiative, International Vaccine Access Center and PATH are focusing on enabling evidence-based policy decisions, improving program quality, providing direct technical assistance in selected countries and monitoring, evaluating and learning to build on the evidence base. Specifically, Jhpiego is supporting the HAPPI/HPV Accelerator-Phase 1 Project to facilitate global coordination and provide HPV vaccine support in several countries, including Côte d’Ivoire.

The people we serve

Empowering Youth in Fighting Against HIV

Mariame Toure* spent her childhood taking medications without understanding why because her mother believed she was too young to be informed of her HIV status. As a teenager, Mariame began questioning why she had to continuously take medication; her mother only told her she had to remain on medication for life to avoid falling ill.

permalink

HIV and TB Can’t Hide in Cote d’Ivoire

The COVID-19 pandemic has interfered with primary health care across the world, not just by overwhelming health care systems, but also by leading people to delay seeking care. This was the case with Kouame.* “At the beginning of October 2022, I started having a fever every night and then a cough and finally I couldn’t

permalink

A New Asset in the Malaria Prevention Toolkit

We spoke with Dr. Christopher Morgan back in March 2024 as countries across Africa were beginning to roll out the malaria vaccine. The insights he shared are just as timely—and urgent—as ever. This piece offers critical context on the vaccine’s potential, the challenges of equitable delivery, and the power of integrating immunization with broader health

permalink

Protecting HIV-Positive Women from Cervical Cancer in Côte d’Ivoire

Abidjan, Côte d’Ivoire—A dozen women are gathered in a spacious, first-floor room at Marcory Hospital one Tuesday, listening to a doctor and midwife explain the risks of cervical cancer and the screening services available at this city health facility. Seated among them is Irene, an HIV-positive mother who has returned to Marcory for her annual cervical cancer screening.

permalink

Country Contact

Kiyali Ouattara, Country Director

Tel. 225 2242 6785

Cocody, II Plateaux

7ème tranche

Lot 3 085 Villa 1

06 BP 2579

Abidjan, Côte d’Ivoire

Current and Recent Donors

Gates Foundation

Gavi, the Vaccine Alliance

Unitaid

USAID